- ►nih.gov GYH Lip, HF Tse - The Lancet, 2007 - Elsevier Atrial fibrillation is the most common sustained cardiac rhythm disorder, and
confers a substantial mortality and morbidity from stroke, thromboembolism,
heart failure, and impaired quality of life. With the increasingly elderly ... Cited by 68 - Related articles - BL Direct - All 37 versions
GYH Lip, HS Lim - Lancet Neurology, 2007 - Elsevier Atrial fibrillation (AF) is a common arrhythmia that is associated with
substantial morbidity and mortality, particularly due to stroke and
thromboembolism. Anticoagulant therapy reduces the risk of stroke, and the ... Cited by 34 - Related articles - All 10 versions
- ►nih.gov Y Blaauw, H Crijns - British Medical Journal, 2008 - heart.bmj.com When confronted with a patient with AF it is important to characterise the
temporal pattern of the arrhythmia according to the 3P classification proposed
in the American College of Cardiology/American Heart Association/European ... Cited by 23 - Related articles - BL Direct - All 9 versions
- ►suc.org.uy [PDF] SJ Connolly, MD Ezekowitz, S Yusuf, J … - New England Journal of Medicine, 2009 - content.nejm.org Stuart J. Connolly, MD, Michael D. Ezekowitz, MB, Ch.B., D.Phil., Salim Yusuf,
FRCPC, D.Phil., John Eikelboom, MD, Jonas Oldgren, MD, Ph.D., Amit Parekh, MD,
Janice Pogue, M.Sc., Paul A. Reilly, Ph.D., Ellison Themeles, BA, Jeanne ... Cited by 31 - Related articles - All 19 versions
D Garcia, E Hylek - The Lancet, 2007 - Elsevier In today's Lancet, Jonathan Mant and colleagues report the results of the
Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study, in which 973
patients, age 75 years and older and with atrial fibrillation, were ... Cited by 19 - Related articles - All 13 versions
RG Hart, MI Aguilar - Journal of thrombosis and thrombolysis, 2008 - Springer Abstract Clinical trials during the past 20 years have revolutionized the
antithrombotic management of atrial fibrillation. Based on consideration of 30
randomized trials involving 29,017 participants, adjusted-dose warfarin ... Cited by 15 - Related articles - BL Direct - All 2 versions
T IssueArticle - Thromb Haemost, 2008 - schattauer.de Summary The risk of stroke in atrial fibrillation (AF) needs to be assessed in
each patient to determine the clinical and cost-effectiveness of
thromboprophylaxis,with the aim of appropriate use of anti- thrombotic ... Cited by 16 - Related articles - BL Direct - All 4 versions
DJ Gladstone, E Bui, J Fang, A Laupacis, MP … - Stroke, 2009 - Am Heart Assoc From the Institute for Clinical Evaluative Sciences (DJG, JF, AL, MPL, JVT, FLS,
MKK), Toronto, Canada; Division of Neurology (DJG, EB, FLS), Department of
Medicine (DJG, JVT), Regional Stroke Centre and Neurosciences Program ... Cited by 17 - Related articles - All 5 versions
S Gretarsdottir, G Thorleifsson, A Manolescu, … - Ann Neurol, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 14 - Related articles - All 6 versions
AJ Rose, A Ozonoff, LE Henault, EM Hylek - J Thromb Haemost, 2008 - interscience.wiley.com Summary. Background: Previous studies of anticoagulation for atrial fibrillation
(AF) have predominantly occurred in academic settings or randomized trials,
limiting their generalizability.Objective: To describe the management of ... Cited by 12 - Related articles - All 3 versions
